Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis
Vittorio Mantero, Damiano Baroncini, Roberto Balgera, Clara Guaschino, Paola Basilico, Pietro Annovazzi, Mauro Zaffaroni, Andrea Salmaggi, Christian Cordano
Topics & Concepts
TeriflunomideMultiple sclerosisCoronavirus disease 2019 (COVID-19)NeuroradiologyNeurologyMedicine2019-20 coronavirus outbreakBetacoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyInternal medicineImmunologyFingolimodPsychiatryDiseaseInfectious disease (medical specialty)OutbreakMultiple Sclerosis Research StudiesLong-Term Effects of COVID-19Peripheral Neuropathies and Disorders